Researchers reviewed how the balance of bacteria in the nose, known as the microbiome, affects people with chronic rhinosinusitis with nasal polyps. They found that when certain bacteria like Staphylococcus aureus increase while others decrease, it can lead to a breakdown in the protective lining of the nose. This imbalance is linked to recurring symptoms and may be influenced by factors like biofilms.
The review looks at different ways to treat this issue. Instead of using broad treatments that kill all bacteria, some experts are looking at precise methods. These include targeted therapies and medications like dupilumab to restore a healthy balance in the nose. This approach aims to fix the underlying environment rather than just treating an infection.
It is important to note that this review focuses on the theory and mechanisms of these treatments. It does not provide data from clinical trials or specific safety results for new drugs. Because these findings are based on a scoping review, they represent early research into how we might better manage long-term sinus issues in the future.
